Patrick B Donnelly
Stock Analyst at Citi
(4.28)
# 1,405
Out of 5,005 analysts
578
Total ratings
53.7%
Success rate
6.6%
Average return
Main Sectors:
Stocks Rated by Patrick B Donnelly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ICLR ICON Public Limited Company | Reiterated: Hold | $165 → $175 | $175.57 | -0.32% | 21 | Sep 18, 2026 | |
| A Agilent Technologies | Reiterated: Buy | $185 → $190 | $175.21 | +8.44% | 38 | Aug 27, 2026 | |
| BRKR Bruker | Reiterated: Hold | $60 → $53 | $63.28 | -16.25% | 31 | Aug 5, 2026 | |
| ILMN Illumina | Reiterated: Sell | $95 → $113 | $271.90 | -58.44% | 44 | Aug 3, 2026 | |
| FTRE Fortrea Holdings | Reiterated: Buy | $22 | $20.06 | +9.67% | 14 | Jul 31, 2026 | |
| DHR Danaher | Reiterated: Buy | $230 | $227.33 | +1.17% | 31 | Jul 22, 2026 | |
| AVTR Avantor | Reiterated: Hold | $9 → $11 | $15.29 | -28.06% | 24 | Jul 8, 2026 | |
| CRL Charles River Laboratories International | Reiterated: Buy | $265 | $294.59 | -10.04% | 24 | Jul 8, 2026 | |
| GH Guardant Health | Reiterated: Buy | $150 → $215 | $177.33 | +21.24% | 23 | Jul 8, 2026 | |
| MTD Mettler-Toledo International | Reiterated: Buy | $1,550 | $1,545.26 | +0.31% | 19 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 → $18 | $10.83 | +66.20% | 17 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $21.41 | +21.44% | 12 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $24 → $45 | $88.50 | -49.15% | 27 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $70 → $73 | $72.51 | +0.68% | 23 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $18.45 | +24.66% | 13 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $28 | $31.75 | -11.81% | 5 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 → $55 | $35.07 | +56.83% | 4 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $55 → $38 | $45.01 | -15.57% | 19 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $375 → $400 | $375.65 | +6.48% | 7 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $375 → $300 | $377.69 | -20.57% | 27 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $200 | $270.97 | -26.19% | 22 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $300 | $411.77 | -27.14% | 3 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $425 | $442.94 | -4.05% | 18 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $685 | $678.60 | +0.94% | 31 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $215 | $237.62 | -9.52% | 20 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $325 | $309.57 | +4.98% | 12 | Jan 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $135 | $151.02 | n/a | 21 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $6 | $3.95 | n/a | 9 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 → $4.25 | $2.02 | n/a | 5 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62 | $24.23 | n/a | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $16.32 | n/a | 9 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $32 → $36 | $28.51 | n/a | 2 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $32 | $4.24 | n/a | 1 | Nov 30, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.5 | $0.0005 | n/a | 1 | Nov 30, 2018 |
ICON Public Limited Company
Sep 18, 2026
Reiterated: Hold
Price Target: $165 → $175
Current: $175.57
Upside: -0.32%
Agilent Technologies
Aug 27, 2026
Reiterated: Buy
Price Target: $185 → $190
Current: $175.21
Upside: +8.44%
Bruker
Aug 5, 2026
Reiterated: Hold
Price Target: $60 → $53
Current: $63.28
Upside: -16.25%
Illumina
Aug 3, 2026
Reiterated: Sell
Price Target: $95 → $113
Current: $271.90
Upside: -58.44%
Fortrea Holdings
Jul 31, 2026
Reiterated: Buy
Price Target: $22
Current: $20.06
Upside: +9.67%
Danaher
Jul 22, 2026
Reiterated: Buy
Price Target: $230
Current: $227.33
Upside: +1.17%
Avantor
Jul 8, 2026
Reiterated: Hold
Price Target: $9 → $11
Current: $15.29
Upside: -28.06%
Charles River Laboratories International
Jul 8, 2026
Reiterated: Buy
Price Target: $265
Current: $294.59
Upside: -10.04%
Guardant Health
Jul 8, 2026
Reiterated: Buy
Price Target: $150 → $215
Current: $177.33
Upside: +21.24%
Mettler-Toledo International
Jul 8, 2026
Reiterated: Buy
Price Target: $1,550
Current: $1,545.26
Upside: +0.31%
Jul 8, 2026
Reiterated: Hold
Price Target: $13 → $18
Current: $10.83
Upside: +66.20%
Jul 8, 2026
Reiterated: Buy
Price Target: $26
Current: $21.41
Upside: +21.44%
Jul 8, 2026
Reiterated: Hold
Price Target: $24 → $45
Current: $88.50
Upside: -49.15%
Jun 29, 2026
Downgraded: Hold
Price Target: $70 → $73
Current: $72.51
Upside: +0.68%
May 28, 2026
Reiterated: Buy
Price Target: $23
Current: $18.45
Upside: +24.66%
May 8, 2026
Reiterated: Buy
Price Target: $35 → $28
Current: $31.75
Upside: -11.81%
May 6, 2026
Reiterated: Buy
Price Target: $60 → $55
Current: $35.07
Upside: +56.83%
Apr 29, 2026
Reiterated: Hold
Price Target: $55 → $38
Current: $45.01
Upside: -15.57%
Apr 24, 2026
Reiterated: Buy
Price Target: $375 → $400
Current: $375.65
Upside: +6.48%
Apr 7, 2026
Downgraded: Hold
Price Target: $375 → $300
Current: $377.69
Upside: -20.57%
Apr 7, 2026
Rated: Hold
Price Target: $200
Current: $270.97
Upside: -26.19%
Apr 7, 2026
Reiterated: Buy
Price Target: $300
Current: $411.77
Upside: -27.14%
Apr 7, 2026
Rated: Buy
Price Target: $425
Current: $442.94
Upside: -4.05%
Apr 6, 2026
Reiterated: Buy
Price Target: $685
Current: $678.60
Upside: +0.94%
Feb 11, 2026
Reiterated: Hold
Price Target: $215
Current: $237.62
Upside: -9.52%
Jan 2, 2026
Reiterated: Buy
Price Target: $325
Current: $309.57
Upside: +4.98%
May 22, 2025
Reiterated: Buy
Price Target: $135
Current: $151.02
Upside: n/a
Feb 26, 2025
Reiterated: Buy
Price Target: $9 → $6
Current: $3.95
Upside: n/a
Mar 23, 2023
Reiterated: Hold
Price Target: $1.5 → $4.25
Current: $2.02
Upside: n/a
Mar 1, 2023
Reiterated: Buy
Price Target: $62
Current: $24.23
Upside: n/a
Feb 24, 2023
Reiterated: Buy
Price Target: $6
Current: $16.32
Upside: n/a
Aug 14, 2019
Reiterated: Hold
Price Target: $32 → $36
Current: $28.51
Upside: n/a
Nov 30, 2018
Upgraded: Hold
Price Target: $32
Current: $4.24
Upside: n/a
Nov 30, 2018
Reiterated: Hold
Price Target: $4.5
Current: $0.0005
Upside: n/a